Corcept Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Corcept Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Corcept Therapeutics Inc
Rating: 1.7595695
Author: Trendlyne DVM scores

Momentum Trap

about

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The...

82.91 -0.34 (-0.41%)

189.29% Gain from 52W Low

719.0K

XNAS Volume

XNAS 12 Jun, 2026 5:30 PM (EDT)

Low Financial Strength

27.8 / 100

Expensive Valuation

27.0 / 100

Technically Neutral

58.2 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 6%

5 analysts

Corcept Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Corcept Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The...

189.29% Gain from 52W Low

SWOT Analysis

Corcept Therapeutics Inc Live Price Chart